Can fake ayurveda medicines cure sexual disorders, impotency? Seizures by Drug Control Admn

HYDERABAD: The Telangana Drugs Control Administration (DCA) has seized eight varieties of ayurvedic medicines from Nalgonda for making misleading claims on their labels and violating the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

The medicines, manufactured by Lifecare Ayurvedic from Rajasthan, made claims to treat diabetes, kidney stones, sexual impotence, obesity, asthma, menstrual disorders, and vision problems, which are prohibited under the Act.

The seized products are

  • Diab Amrit Capsules (claimed to treat diabetes)
  • Stone Crush Capsules and Syrup (claimed to treat kidney stones)
  • Sleemocare Kit Powder and Capsule (claimed to treat obesity)
  • Sperm Grow Kit Powder and Capsule (claimed to treat sexual impotence)
  • Migrocare Capsules (claimed to treat vision problems)
  • Cysto Care Syrup (claimed to treat irregular menstruation)
  • Asthma Care Capsules (claimed to treat asthma)

The raid took place at Sri Siddhi Vinayaka Medical Hall in Nalgonda. DCA officials said that the seized medicines were worth Rs 2,750.

“Persons who make misleading advertisements regarding drugs for treatment of certain diseases and disorders are punishable under Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, with imprisonment which may extend to six months, or with fine, or with both,” the DCA said.

The authorities said that further investigation was underway and action would be taken against all offenders as per the law.

Related Posts

  • Pharma
  • July 24, 2025
  • 294 views
Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

  • Pharma
  • July 22, 2025
  • 343 views
DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra